Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Sernova Biotherapeutics Inc. (SEOVF) had Stock-Based Compensation of $0.53M for the most recently reported fiscal quarter, ending 2025-01-31.
| Income Statement Financials | |
-- |
|
$-4.16M |
|
-- |
|
-- |
|
$3.50M |
|
$-3.50M |
|
$-0.65M |
|
$-4.15M |
|
$-4.15M |
|
$-4.16M |
|
$-4.16M |
|
$-4.16M |
|
$-4.16M |
|
$-3.50M |
|
$-3.47M |
|
327.47M |
|
327.47M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$1.51M |
|
$0.21M |
|
$0.74M |
|
$2.25M |
|
$15.01M |
|
$0.32M |
|
$0.32M |
|
$15.33M |
|
$-13.08M |
|
$-13.08M |
|
$-13.08M |
|
328.49M |
|
| Cash Flow Statement Financials | |
$-3.52M |
|
-- |
|
$0.02M |
|
$4.39M |
|
$0.88M |
|
$-3.51M |
|
|
Stock-Based Compensation |
$0.53M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.10 |
|
-- |
|
-- |
|
-0.03 |
|
-0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
31.77% |
|
31.77% |
|
-185.01% |
|
32.57% |
|
$-0.04 |
|
$-0.01 |
|
$-0.01 |
|